Influence of Particle Aspect Ratio on Translational Collision Dynamics in Wall‐Bounded Turbulence
Chemical Engineering & Technology · 2026-06 · 49 (6)
DOI: 10.1002/ceat.70262 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Engineering & Technology, online erschienen am 25.06.2026. Verfasst von Connor H. Nolan und 3 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This study examines how particle shape influences collision dynamics in turbulent channel flow using direct numerical simulation (DNS) with Lagrangian tracking and fully resolved four‐way coupling. Rigid ellipsoids across aspect ratios are simulated with inertia‐driven translation, hydrodynamic forces, and quaternion‐based rotation. Needle‐like particles align more strongly with the local shear, reducing turbulent scattering and producing lower collision velocities with narrower angle distributions. Nearly spherical particles respond more intensely to turbulence, yielding broader collision statistics. Some features, such as spanwise velocity fluctuations, remain largely shape‐independent, highlighting the dominance of lateral turbulent motions.
Zitieren
APA
Nolan, C. H., Mortimer, L. F., Jimack, P. K., & Fairweather, M. (2026). Influence of Particle Aspect Ratio on Translational Collision Dynamics in Wall‐Bounded Turbulence. Chemical Engineering & Technology, 49(6). https://doi.org/10.1002/ceat.70262
Vancouver
Nolan CH, Mortimer LF, Jimack PK, Fairweather M. Influence of Particle Aspect Ratio on Translational Collision Dynamics in Wall‐Bounded Turbulence. Chemical Engineering & Technology. 2026;49(6). doi:10.1002/ceat.70262
BibTeX
@article{Nolan2026,
author = {Nolan, Connor H. and Mortimer, Lee F. and Jimack, Peter K. and Fairweather, Michael},
title = {Influence of Particle Aspect Ratio on Translational Collision Dynamics in Wall‐Bounded Turbulence},
journal = {Chemical Engineering & Technology},
year = {2026},
volume = {49},
number = {6},
doi = {10.1002/ceat.70262}
}
EUVIMED